Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -7,75k | 13,71k | Sale to Issuer | 1,77 | 610,63k | -1,25% |
| 2026-06-15 | Mr. Samuel C. WilsonCEO & Director | -40,07k | 70,92k | Sale to Issuer | 1,77 | 2,60M | -1,52% |
| 2026-06-15 | Dr. Hunter MiddletonChief Product Officer | -16,11k | 28,52k | Sale to Issuer | 1,77 | 893,69k | -1,77% |
| 2026-06-15 | Mr. Kevin KrausCFO & Principal Accounting Officer | -17,85k | 31,60k | Sale to Issuer | 1,77 | 992,65k | -1,77% |
| 2026-06-15 | Ms. Suzanne SeandelInsider | -5,79k | 10,25k | Sale to Issuer | 1,77 | 301,16k | -1,89% |
| 2026-06-06 | Mr. Samuel C. WilsonCEO & Director | -104,22k | 196,98k | Sale to Issuer | 1,89 | 2,64M | -3,80% |
| 2026-06-06 | Ms. Suzanne SeandelInsider | -25,57k | 48,32k | Sale to Issuer | 1,89 | 295,56k | -7,96% |
| 2026-06-06 | Dr. Hunter MiddletonChief Product Officer | -40,91k | 77,31k | Sale to Issuer | 1,89 | 909,80k | -4,30% |
| 2026-06-06 | Mr. Kevin KrausCFO & Principal Accounting Officer | -42,61k | 80,54k | Sale to Issuer | 1,89 | 1,01M | -4,05% |
| 2026-06-06 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -25,40k | 48,01k | Sale to Issuer | 1,89 | 618,38k | -3,95% |
| 2026-05-27 | Ms. Suzanne SeandelInsider | -27,15k | 57,57k | Sale to Issuer | 2,12 | 270,88k | -9,11% |
| 2026-05-27 | Mr. Samuel C. WilsonCEO & Director | -141,70k | 300,39k | Sale to Issuer | 2,12 | 1,94M | -6,81% |
| 2026-05-27 | Dr. Hunter MiddletonChief Product Officer | -56,25k | 119,25k | Sale to Issuer | 2,12 | 699,46k | -7,44% |
| 2026-05-27 | Mr. Kevin KrausCFO & Principal Accounting Officer | -60,95k | 129,21k | Sale to Issuer | 2,12 | 701,37k | -7,99% |
| 2026-05-27 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -32,10k | 68,05k | Sale to Issuer | 2,12 | 409,28k | -7,27% |
| 2026-02-09 | Sylebra Capital ManagementSocietà | -2,20M | 5,91M | Vendita | 1,62 - 2,69 | 8,37M | -20,81% |
| 2026-03-15 | Dr. Hunter MiddletonChief Product Officer | -17,79k | 37,18k | Sale to Issuer | 2,09 | 645,15k | -2,68% |
| 2026-03-15 | Ms. Suzanne SeandelInsider | -6,40k | 13,37k | Sale to Issuer | 2,09 | 244,66k | -2,55% |
| 2026-03-15 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -8,76k | 18,31k | Sale to Issuer | 2,09 | 368,01k | -2,33% |
| 2026-03-15 | Mr. Kevin KrausCFO & Principal Accounting Officer | -19,71k | 41,20k | Sale to Issuer | 2,09 | 642,53k | -2,98% |
| 2026-03-15 | Mr. Samuel C. WilsonCEO & Director | -41,82k | 87,40k | Sale to Issuer | 2,09 | 1,80M | -2,27% |
| 2026-02-17 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -5,00k | 12,73k | Automatic Disposition | 2,55 | 376,77k | -1,31% |
| 2026-01-06 | Sylebra Capital ManagementSocietà | -1,44M | 3,83M | Vendita | 1,61 - 2,67 | 9,96M | -12,61% |
| 2026-02-04 | Dr. Hunter MiddletonChief Product Officer | -85,04k | 212,81k | Automatic Disposition | 2,50 | 652,94k | -11,52% |
| 2025-12-11 | Sylebra Capital ManagementSocietà | -1,85M | 3,79M | Vendita | 1,94 - 2,22 | 11,39M | -13,97% |
| 2025-12-15 | Dr. Hunter MiddletonChief Product Officer | -16,08k | 33,12k | Sale to Issuer | 2,06 | 737,99k | -2,13% |
| 2025-12-15 | Mr. Kevin KrausCFO & Principal Accounting Officer | -17,82k | 36,71k | Sale to Issuer | 2,06 | 662,24k | -2,62% |
| 2025-12-15 | Mr. Samuel C. WilsonCEO & Director | -39,99k | 82,38k | Sale to Issuer | 2,06 | 1,83M | -2,13% |
| 2025-12-15 | Ms. Suzanne SeandelInsider | -5,78k | 11,91k | Sale to Issuer | 2,06 | 321,85k | -1,76% |
| 2025-12-15 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -9,84k | 20,27k | Sale to Issuer | 2,06 | 381,77k | -2,51% |
| 2025-12-01 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -5,00k | 9,76k | Automatic Disposition | 1,95 | 391,61k | -1,26% |
| 2025-09-15 | Mr. Laurence DennyChief Legal Officer & Corporate Secretary | -22,15k | 47,17k | Sale to Issuer | 2,13 | 396,61k | -5,29% |
| 2025-09-15 | Dr. Hunter MiddletonChief Product Officer | -38,93k | 82,92k | Sale to Issuer | 2,13 | 754,07k | -4,91% |
| 2025-09-15 | Mr. Kevin KrausCFO & Principal Accounting Officer | -43,21k | 92,03k | Sale to Issuer | 2,13 | 680,06k | -5,97% |
| 2025-09-15 | Mr. Samuel C. WilsonCEO & Director | -97,12k | 206,86k | Sale to Issuer | 2,13 | 1,87M | -4,93% |
| 2025-09-15 | Ms. Suzanne SeandelInsider | -14,67k | 31,24k | Sale to Issuer | 2,13 | 224,06k | -6,14% |
| 2025-07-28 | Ms. Elizabeth Harriet TheophilleIndependent Director | -24,27k | 49,76k | Vendita | 2,05 | 120,79k | -16,73% |
| 2025-07-15 | Ms. Suzanne SeandelInsider | -10,30k | 19,88k | Sale to Issuer | 1,93 | 209,83k | -4,68% |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
